StockData
Merck & Co., Inc. logo

Merck & Co., Inc.

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$148.36−1.16 (-0.78%)

Close on Nov 2, 2026Market cap $366.03BP/E 118.7Yield 2.21%

Merck Collaboration by Quarter

Collaboration — AstraZeneca (Lynparza & Koselugo Oncology Alliance) ($M) ($M)

QuarterlyAnnual

Merck Collaboration: $84M in Q2 2026, down 2.3% from a year earlier.

Latest, Q2 2026
84
Period ended Jun 30, 2026
Change on a year earlier
-2.3%
86 in Q2 2025
History
32 quarters
Since Q3 2017
Sources
27
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-07) ↗

Reported in Form 10-Q / 10-K Note 3/4 Collaborative Arrangements.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCollaboration — AstraZeneca (Lynparza & Koselugo Oncology Alliance) ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202684-2.3%Form 10-Q (filed 2026-08-07) ↗
Q1 2026Mar 31, 202684+1.2%Form 10-Q (filed 2026-05-04) ↗
Q4 2025Dec 31, 202585-36.1%Form 10-K (filed 2026-02-24) ↗
Q3 2025Sep 30, 202584+2.4%Form 10-Q (filed 2025-11-05) ↗
Q2 2025Jun 30, 202586+4.9%Form 10-Q (filed 2026-08-07) ↗
Q1 2025Mar 31, 202583+1.2%Form 10-Q (filed 2026-05-04) ↗
Q4 2024Dec 31, 2024133+64.2%Form 10-K (filed 2026-02-24) ↗
Q3 2024Sep 30, 2024820.0%Form 10-Q (filed 2025-11-05) ↗
Q2 2024Jun 30, 202482+5.1%Form 10-Q (filed 2025-08-05) ↗
Q1 2024Mar 31, 202482+17.1%Form 10-Q (filed 2025-05-02) ↗
Q4 2023Dec 31, 202381+20.9%Form 10-K (filed 2026-02-24) ↗
Q3 2023Sep 30, 202382+28.1%Form 10-Q (filed 2024-11-06) ↗
Q2 2023Jun 30, 202378+25.8%Form 10-Q (filed 2024-08-05) ↗
Q1 2023Mar 31, 202370-76.6%Form 10-Q (filed 2024-05-03) ↗
Q4 2022Dec 31, 202267+59.5%Form 10-K (filed 2025-02-25) ↗
Q3 2022Sep 30, 202264+52.4%Form 10-Q (filed 2023-11-03) ↗

Breakdown

What makes up collaboration

Cite this data

StockData. (2026). Merck Collaboration ($M), quarterly Q3 2017–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/collab-astrazeneca

See every metric in the Merck KPI table. Data updated Oct 26, 2026.